NCT00921713

Brief Summary

The purpose of this proposal is to develop and test the efficacy in a randomized, controlled clinical trial of an Oncology Nurse Care Management (ONCM) program to support cancer patients early in their course. The ONCM program will be compared with an Enhanced Usual Care (EUC) program that will provide education materials and treatment resources for patients. Efficacy will be measured by differences over time in participant-reported Quality of Life, Symptoms and Emotional Distress, and Quality of Care between patients receiving ONCM versus EUC.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable cancer

Timeline
Completed

Started Sep 2008

Longer than P75 for not_applicable cancer

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2009

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 16, 2009

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

October 13, 2017

Status Verified

October 1, 2017

Enrollment Period

2.8 years

First QC Date

June 4, 2009

Last Update Submit

October 11, 2017

Conditions

Keywords

Early cancer care

Outcome Measures

Primary Outcomes (1)

  • Quality of life and satisfaction with care between patients in Oncology Nurse Care Management versus Enhanced Usual Care

    5/2009 - 8/2011

Secondary Outcomes (1)

  • Treatment adherence and treatment outcomes of patients in Oncology Nurse Care Management versus Enhanced Usual Care

    5/2009 - 8/2011

Study Arms (2)

Enhanced Usual Care

ACTIVE COMPARATOR

An extensive packet of information including cancer education materials and treatment resources will be mailed to patients.

Other: Patient-centered materials

Oncology Nurse Care Management

EXPERIMENTAL

In addition to this mailed information packet, patients in OCNM will be contacted by an experienced Oncology nurse with additional training in self-management support and psychosocial care. The intervention nurse, supported by a Medical Oncologist and Clinical Psychologist, will work closely with patients, their primary care physicians, and other clinicians to assure that patient needs discussed are met. The nurses will be trained in and employ proven counseling and psychotherapeutic approaches-behavioral activation and problem-solving treatment. The multi-component intervention will be based on the Chronic Care Model's six elements (health care organization, community resources, self-management support, delivery system design, decision support, and clinical information system).

Other: Oncology Nurse Care Management

Interventions

Oncology Nurse Care Management
Enhanced Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • On the panel of an eligible and consenting primary care physician;
  • Diagnosed with a new occurrence of breast (females only) , colorectal, or lung cancer within the past three weeks;
  • Age 18 or older; and
  • Able to complete the baseline questionnaire.

You may not qualify if:

  • They plan to disenroll from GH or be out of the area in the coming year; or
  • Primary care physician or specialty physician expects survival to be less than 12 months; or
  • Don't speak English; or
  • Have moderate cognitive impairment (a score of 3 or more on a six-item validated instrument, or psychosis as assessed by ICD-9 codes from GH medical record data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Edward Wagner, MD, MPH

    Group Health Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2009

First Posted

June 16, 2009

Study Start

September 1, 2008

Primary Completion

July 1, 2011

Study Completion

August 1, 2013

Last Updated

October 13, 2017

Record last verified: 2017-10